Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
05/2010
05/04/2010US7709464 Drud delivery; prolonging the time a pharmaceutical drug circulates in the blood of a subject by using a liposome containing the inventive compound as a carrier
05/04/2010US7709384 Tantalum amide complexes for depositing tantalum-containing films, and method of making same
05/04/2010US7709263 use of the complexes obtained as fluorescent markers, and as relaxation agents for NMR or for NMR imaging; [Eu.(1-4H).H2O]Na
05/04/2010US7709020 Implantable device comprising phosphorus-containing macrolides
05/04/2010CA2504496C N-oxides and derivatives of melphalan for treating diseased states associated with hypoxia inducible factor
05/04/2010CA2458812C Solid-liquid reaction
05/04/2010CA2439001C Water-soluble triazole antifungal agents
04/2010
04/30/2010CA2642563A1 Iron(ii) catalysts containing diimino-diphosphine tetradentate ligands and their synthesis
04/29/2010WO2010048121A1 Mixed glycol polyphosphonate compounds
04/29/2010WO2010047296A1 NOVEL PYRIMIDINE DERIVATIVE AND METHOD FOR PRODUCING HMG-CoA REDUCTASE INHIBITOR INTERMEDIATE
04/29/2010WO2010046898A1 A process for the preparation of halogenated aryl phosphonates
04/29/2010WO2010046540A1 Nucleic acid binding peptide
04/29/2010WO2010046259A1 Polycyclic compounds for electronic applications
04/29/2010WO2010046026A1 Olefinically unsaturated phosphonate compounds, polymers made therefrom and their use
04/29/2010WO2010045895A2 A process for preparing n-(hydrocarbyl) phosphoric or thiophosphoric triamides
04/29/2010WO2008121194A8 Hydroformylation process
04/29/2010US20100105939 Phosphorus-containing compound and method for preparing the same
04/29/2010US20100105566 Enzyme-Catalyzed Metal Deposition for the Enhanced Detection of Analytes of Interest
04/29/2010US20100102277 Stabilized semiconductor nanocrystals
04/29/2010CA2743356A1 Mixed glycol polyphosphonate compounds
04/29/2010CA2741348A1 Olefinically unsaturated phosphonate compounds, polymers made therefrom and their use
04/29/2010CA2738839A1 A process for preparing n-(hydrocarbyl) phosphoric or thiophosphoric triamides
04/28/2010EP2180004A1 Olefinically unsaturated phosphonate compounds, polymers made therefrom and their use
04/28/2010EP2180003A1 Preparation of ibandronate trisodium
04/28/2010EP2180002A1 Method for producing onium salts with dialkyl phosphonate anions with low halogenide content
04/28/2010EP2178891A2 Phosphonous acids, salts and esters, methods for the production thereof, and use of same
04/28/2010EP2178890A1 Purification of rosuvastatin intermediate by thin film evaporation and chemical method
04/28/2010EP2178887A1 Method for preparing a solution of a rare-earth organophosphate in an organic solvent
04/28/2010EP2178846A1 Rosuvastatin intermediates and their preparation
04/28/2010EP2178837A2 Isophthalamide derivatives inhibiting beta-secretase activity
04/28/2010EP1656395B1 Process for the preparation of a metalloorganic compound comprising at least one imine ligand
04/28/2010EP1654292B1 Process for the preparation of a metal-organic compound comprising at least one imine ligand
04/28/2010EP1651681B1 Process for the preparation of a metalloorganic compound comprising at least one imine ligand
04/28/2010EP1572359B1 Monocyclopentadienyl complexes
04/28/2010EP1569663B1 Ifosfamide compositions for parenteral administration and a process for their preparation
04/28/2010CN201441905U Automatic alkyl phosphorothioate feeding device
04/28/2010CN1948321B Preparation method of bi (2,4-bicumene phenyl) tetra methylomethane biphosphite ester
04/28/2010CN1832939B Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
04/28/2010CN1729155B Cyclohexane derivatives and methods for their preparation
04/28/2010CN1726220B Process for the preparation of phosphitylation agents
04/28/2010CN1690066B Antiviral agent cidofovir derivatives
04/28/2010CN1627990B Method for hydroformylation using catalyst of xanthene-bridged ligands
04/28/2010CN101698671A Method for preparing glyphosate by PMIDA catalytic oxidation
04/27/2010US7705188 protecting 3,5-DIhydroxybenzaldehyde with diisopropylethylamine/N,N-/ and silyl chloride, reacting 3,5-di(tert-butyldimethylsilyloxy)-benzaldehyde product with 4-methoxybenzyltriphenylphosphonium bromide to obtain 3,5-di(tert-butyldimethylsilyloxy)-4'-methoxy-stilbene, deprotecting and separating
04/27/2010US7705178 Altering the crystal size distribution of N-(phosphonomethyl) iminodiacetic acid for improved filtration and product quality
04/27/2010US7705177 t-Butyl 1-[9-[1-(tert-butoxycarbonyl)cyclopropyl]-5-oxononyl]-1-cyclopropanecarboxylate; Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, impotence
04/27/2010US7705176 for use in food, plastics, elastomers, composites and petroleum based products; heat resistance
04/27/2010US7705074 Aqueous polymerization of fluorinated monomer using polymerization agent comprising fluoropolyether acid or salt and short chain fluorosurfactant
04/27/2010US7705065 making a functionalized photoinitiator by reacting photoinitiator with selected alcohol-ethers; use in inks
04/27/2010US7704999 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
04/27/2010US7704912 metal complexes for used in hydrogenation, hydroformylation, hydroboration, hydrosilylation, hydrovinylation, hydroamination, epoxidation, hydroxylation, Michael addition, aldol addition, Diels-Alder reaction; enantioselective
04/22/2010WO2010044686A1 Akr1c3 as a biomarker, methods of selecting and treating patients based upon an akr1c3 profile and compounds for use therein
04/22/2010WO2010044685A1 Nitrophenyl mustard alcohols, their corresponding phosphates and their use as targeted cytotoxic agents
04/22/2010WO2010044523A1 Method for introducing functional group to surface of material
04/22/2010WO2010043180A1 Ethoxy diphenyl ethane derivates, preparation processes and uses thereof
04/22/2010WO2010043000A1 S1p receptors modulators and their use thereof
04/22/2010US20100099902 Chiral phosphanes for use in asymmetric syntheses
04/22/2010US20100099900 Delta-8 desaturases and their use in making polyunsaturated fatty acids
04/22/2010US20100099876 Method of preparing montelukast and intermediates used therein
04/22/2010US20100099875 New ortho-functionalized p-chiral arylphosphines and derivatives: their preparation and use in asymmetric catalysis
04/22/2010US20100099869 Novel nucleotide analogues as precusor molecules for antivirals
04/22/2010US20100099649 Site-specific chemical modification of proteins at their n-termini, enabling the formation of homogeneous adducts
04/22/2010US20100099118 Methods of determining total pon1 level
04/22/2010US20100098641 Monophosphates as Mutual Prodrugs of Anti-Inflammatory Signal Transduction Modulators (AISTM's) and Beta-Agonists for the Treatment of Pulmonary Inflammation and Bronchoconstriction
04/22/2010CA2740484A1 S1p receptors modulators and their use thereof
04/21/2010EP2177525A1 Metal complex compound, cancer therapeutic composition comprising the metal complex compound as active ingredient, and intermediate for production of the metal complex compound
04/21/2010EP2176275A1 Adefovir dipivoxil crystalline monohydrate form
04/21/2010EP2176274A2 Mixed fluoroalkyl-alkyl surfactants
04/21/2010EP1620082B1 Medical use of inhibitors of glutaminyl and glutamate cyclases for treating alzheimer's disease and down syndrome
04/21/2010CN101696225A Material recycling method in preparation of N-(Phosphonomethyl) iminodiacetic acid
04/21/2010CN101696224A Method for synthesizing di(isooctyl) phosphate
04/21/2010CN101696223A Synthesis method of citric acid phosphoric acid ester
04/21/2010CN101696208A Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists
04/21/2010CN101695673A Method for preparing chitosan immobilized Lewis acidic ionic liquid and DCPP synthesized by using chitosan immobilized Lewis acidic ionic liquid in presence of high-efficient catalyst
04/20/2010USRE41252 Peptidyl prodrugs and linkers and stabilizers useful therefor
04/20/2010US7700807 Process to prepare alkyl phenyl phosphates
04/20/2010US7700795 Use of azeotropically dried nickel(ii) halogenides
04/20/2010US7700792 Highly active lysophosphatidic acid and method of screening therewith
04/20/2010US7700777 Crystalline forms of a biphenyl compound
04/20/2010US7700649 Such as 1,2-Ethanediamine-trans-dihydroxo(dihydrogen pyrophosphato)platinum(IV)
04/20/2010US7700550 Telavancin or its hydrochloride salt for infection, including MRSA infections; reduced tissue accumulation and/or nephrotoxicity
04/20/2010CA2640748C Methods for the diagnosis of dementia and other neurological disorders
04/20/2010CA2417935C Anti-inflammatory medicament
04/20/2010CA2358925C Compositions and methods for use in targeting vascular destruction
04/20/2010CA2348741C Nitrosasted and nitrosylated nonsteroidal antiinflammatory compounds, comositions and methods of use
04/15/2010WO2010042313A1 Slurry process for synthesis of bisphosphites
04/15/2010WO2010041242A2 Oxidized thiophospholipid compounds and uses thereof
04/15/2010WO2010041144A2 Beta-hydroxy-gamma-aminophosphonates and methods for the preparation and use thereof
04/15/2010WO2010040741A1 Niobium and vanadium organometallic precursors for thin film deposition
04/15/2010WO2009152906A3 Use of ionic liquids with tetracyanoborate anions as a solvent for extraction of alcohols from aqueous solutions
04/15/2010WO2009148878A3 Method of forming functionalized silanes
04/15/2010WO2009148600A3 Deuterated lysine-based compounds
04/15/2010US20100094042 produces stable regiospecific and/or stereospecific dithiophosphinic acid that can operate in acidic media
04/15/2010US20100094020 Polycationized phospholipid derivatives
04/15/2010US20100094012 Heterodiamondoids
04/15/2010US20100094001 Composition containing stability-improved chloromethyl phosphate derivative and process for producing same
04/15/2010US20100093985 Use of at least one cytosolic phospholipase a2 inhibitor as a medicine for symptomatic treatment of mucoviscidosis
04/15/2010US20100093899 Resin additive master batch
04/15/2010US20100093708 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
04/15/2010US20100093671 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use